# CLINICAL SIGNOFF REPORT
## DeepSynaps Protocol Studio - Controlled Pilot Sign-Off

**Date:** [TO BE FILLED BY CLINICAL TEAM]  
**Status:** Clinical Review Phase  
**Prepared by:** Clinical Safety Review Team

---

## EXECUTIVE SUMMARY

This report documents clinical team's formal approval or rejection of the controlled pilot for DeepSynaps Protocol Studio consent enforcement.

**Verdict:** [Clinical team must select one]
- [ ] **APPROVED FOR CONTROLLED PILOT** — All sign-offs passed
- [ ] **APPROVED WITH CHANGES** — Approved pending specific modifications
- [ ] **NOT APPROVED** — Clinical team recommends blocking pilot

---

## REQUIRED CLINICAL SIGN-OFFS

### Sign-Off 1: Consent UX is Understandable ✅ / ❌ / 🔄

**Question:** Do clinicians understand what "Patient consent is required" means in the context of blocked workflows?

**Evidence reviewed:**
- [x] CONTROLLED_PILOT_READINESS_REPORT.md (consent UX section)
- [x] consent-error-handler.test.js (message test cases)
- [x] CLINICAL_REVIEW_PACK.md (UX guidelines)
- [x] Staging deployment with live UX

**Clinical feedback:**
```
Is the UX message clear and actionable?

[ ] Clear - Clinicians immediately understand
[ ] Mostly clear - Minor improvements needed
[ ] Confusing - Significant changes needed
[ ] Unsafe - Message creates confusion or risk

Specific feedback: _______________________________________________
```

**Clinical Lead sign-off:**
- [ ] **APPROVED** — UX is understandable
- [ ] **APPROVED WITH CHANGES** — UX clear but needs: _______________
- [ ] **NOT APPROVED** — UX is confusing or unsafe

Clinical Lead name: ________________________  
Signature: ________________________  Date: __________

---

### Sign-Off 2: Missing-Consent Blocking is Clinically Acceptable ✅ / ❌ / 🔄

**Question:** Is it clinically safe and appropriate to block workflows when patient consent is missing?

**Evidence reviewed:**
- [x] CLINICAL_REVIEW_PACK.md (consent types and protection scope)
- [x] CONTROLLED_PILOT_READINESS_REPORT.md (blocking behavior)
- [x] DATABASE_VERIFICATION_CHECKLIST.md (verification that workflows truly block)

**Clinical feedback:**
```
Is blocking workflows when consent is missing clinically acceptable?

[ ] Yes - Appropriate protection level
[ ] Mostly - Protection too strict in: _______________
[ ] Too restrictive - Should allow: _______________
[ ] Unsafe - Creates clinical risk

Rationale: _______________________________________________
```

**Clinical Lead sign-off:**
- [ ] **APPROVED** — Blocking is clinically acceptable
- [ ] **APPROVED WITH CHANGES** — Blocking is acceptable but: _______________
- [ ] **NOT APPROVED** — Blocking creates clinical risk

Clinical Lead name: ________________________  
Signature: ________________________  Date: __________

---

### Sign-Off 3: Valid-Consent Workflows are Clear ✅ / ❌ / 🔄

**Question:** When consent IS valid, are the workflows clear, intuitive, and safe for clinicians?

**Evidence reviewed:**
- [x] consent-error-handler.test.js (success scenarios)
- [x] CONTROLLED_PILOT_READINESS_REPORT.md (allowed workflows)
- [x] Staging deployment with live workflows
- [x] CONTROLLED_PILOT_PLAN.md (scenario definitions)

**Clinical feedback:**
```
Are valid-consent workflows clear and safe?

[ ] Yes - Workflows are clear and intuitive
[ ] Mostly - Workflow needs improvement in: _______________
[ ] Confusing - Needs significant changes: _______________
[ ] Unsafe - Creates clinical risk

Suggestions: _______________________________________________
```

**QA Lead sign-off:**
- [ ] **APPROVED** — Workflows are clear and safe
- [ ] **APPROVED WITH CHANGES** — Workflows are safe but: _______________
- [ ] **NOT APPROVED** — Workflows are confusing or unsafe

QA Lead name: ________________________  
Signature: ________________________  Date: __________

---

### Sign-Off 4: No Unsafe Clinical Claims ✅ / ❌ / 🔄

**Question:** Does the system avoid unsafe clinical language such as autonomous diagnosis, prescribing claims, or diagnostic certainty statements?

**Evidence reviewed:**
- [x] consent-error-handler.test.js (security tests, line 200+)
- [x] CLINICAL_REVIEW_PACK.md (clinical claims policy)
- [x] CONTROLLED_PILOT_READINESS_REPORT.md (wording review)
- [x] Staging deployment live messages

**Clinical feedback:**
```
Are there any unsafe clinical claims or language?

[ ] No unsafe claims - Language is appropriate
[ ] Minor issues - Language could be clearer in: _______________
[ ] Concerning - Language implies: _______________
[ ] Unsafe - Should be blocked

Examples of concerns: _______________________________________________
```

**Compliance Officer sign-off:**
- [ ] **APPROVED** — No unsafe clinical claims
- [ ] **APPROVED WITH CHANGES** — Language needs: _______________
- [ ] **NOT APPROVED** — Clinical claims are unsafe

Compliance Officer name: ________________________  
Signature: ________________________  Date: __________

---

### Sign-Off 5: No Autonomous Diagnosis/Prescribing Language ✅ / ❌ / 🔄

**Question:** Does the system explicitly avoid implying autonomous diagnosis capability or prescribing authority?

**Evidence reviewed:**
- [x] CLINICAL_REVIEW_PACK.md (disclaimers, line 300+)
- [x] consent-error-handler.test.js (security tests)
- [x] CONTROLLED_PILOT_READINESS_REPORT.md (autonomous claims section)
- [x] Output messages and disclaimers

**Clinical feedback:**
```
Does the system imply autonomous diagnosis or prescribing?

[ ] No - Language is clearly not diagnostic/prescriptive
[ ] Mostly clear - One phrase could be misinterpreted: _______________
[ ] Ambiguous - Could imply autonomy in: _______________
[ ] Unsafe - Implies autonomous capability

Specific concerns: _______________________________________________
```

**Compliance Officer sign-off:**
- [ ] **APPROVED** — No autonomous diagnosis/prescribing language
- [ ] **APPROVED WITH CHANGES** — Language needs clarification: _______________
- [ ] **NOT APPROVED** — Language implies autonomous capability

Compliance Officer name: ________________________  
Signature: ________________________  Date: __________

---

### Sign-Off 6: Patient/Clinician Wording is Acceptable ✅ / ❌ / 🔄

**Question:** Is the wording appropriate for both patient-facing and clinician-facing contexts?

**Evidence reviewed:**
- [x] CLINICAL_REVIEW_PACK.md (patient/clinician contexts)
- [x] consent-error-handler.test.js (message content tests)
- [x] CONTROLLED_PILOT_READINESS_REPORT.md (wording review)

**Clinical feedback:**
```
Is the wording appropriate for intended audiences?

[ ] Yes - Clear for patients and clinicians
[ ] Mostly - Better for clinicians than patients (or vice versa)
[ ] Confusing - Wording should be: _______________
[ ] Inappropriate - Should use: _______________

Suggestions for improvement: _______________________________________________
```

**Clinical Lead sign-off:**
- [ ] **APPROVED** — Wording is appropriate
- [ ] **APPROVED WITH CHANGES** — Wording needs: _______________
- [ ] **NOT APPROVED** — Wording is inappropriate

Clinical Lead name: ________________________  
Signature: ________________________  Date: __________

---

### Sign-Off 7: Escalation Path is Clear ✅ / ❌ / 🔄

**Question:** When consent is missing and a workflow is blocked, is it clear what the next step is (how to obtain/review consent)?

**Evidence reviewed:**
- [x] CLINICAL_REVIEW_PACK.md (escalation path, line 400+)
- [x] consent-error-handler.test.js (action guidance tests)
- [x] CONTROLLED_PILOT_READINESS_REPORT.md (workflow guidance)
- [x] Staging deployment with live messages

**Clinical feedback:**
```
Is the escalation path clear when consent is missing?

[ ] Yes - Clear next steps to obtain consent
[ ] Mostly - Clear for most workflows but: _______________
[ ] Unclear - Patient doesn't know what to do
[ ] Missing - No guidance provided

What should the next step be? _______________________________________________
```

**Clinical Lead sign-off:**
- [ ] **APPROVED** — Escalation path is clear
- [ ] **APPROVED WITH CHANGES** — Path needs clarification: _______________
- [ ] **NOT APPROVED** — Escalation path is unclear

Clinical Lead name: ________________________  
Signature: ________________________  Date: __________

---

### Sign-Off 8: Staging-Only Pilot Can Proceed ✅ / ❌ / 🔄

**Question:** Is the clinical team comfortable proceeding with a controlled 10-20 workflow pilot in staging (no real patients)?

**Evidence reviewed:**
- [x] All 7 prior sign-offs
- [x] CONTROLLED_PILOT_PLAN.md (pilot scope and safeguards)
- [x] DATABASE_VERIFICATION_CHECKLIST.md (verification rigor)
- [x] Staging environment verification (13/13 checks)

**Clinical feedback:**
```
Is the clinical team comfortable with staging-only pilot?

[ ] Yes - Ready to proceed with pilot
[ ] Mostly - Ready with conditions: _______________
[ ] Hesitant - Need changes before: _______________
[ ] No - Should not proceed

Conditions or concerns: _______________________________________________
```

**Clinical Lead sign-off:**
- [ ] **APPROVED** — Pilot can proceed
- [ ] **APPROVED WITH CONDITIONS** — Pilot can proceed if: _______________
- [ ] **NOT APPROVED** — Pilot should not proceed

Clinical Lead name: ________________________  
Signature: ________________________  Date: __________

---

## OVERALL CLINICAL VERDICT

Based on the 8 sign-offs above, clinical team's overall verdict:

### ✅ APPROVED FOR CONTROLLED PILOT

**Conditions:**
- All 8 sign-offs: Approved
- No required changes
- Pilot can proceed immediately

**Authorization:**
- Approved by Clinical Lead: ________________________
- Approved by Compliance Officer: ________________________
- Approved by QA Lead: ________________________

**Next step:** Proceed to pilot execution (May 14-16)

---

### 🔄 APPROVED WITH CHANGES

**Required changes:**
1. _______________________________________________
2. _______________________________________________
3. _______________________________________________

**Timeline to implement:** _______________
**Follow-up review date:** _______________

**Authorization:**
- Clinical Lead: ________________________
- Compliance Officer: ________________________

**Next step:** Engineering team implements changes, clinical re-review, then pilot

---

### ❌ NOT APPROVED

**Blocking issues:**
1. _______________________________________________
2. _______________________________________________
3. _______________________________________________

**Clinical rationale:** _______________________________________________

**Recommendation:** _______________________________________________

**Authorization:**
- Clinical Lead: ________________________
- Compliance Officer: ________________________

**Next step:** Halt pilot, address issues, schedule re-review

---

## CLINICAL TEAM FEEDBACK

### Overall Assessment

**Confidence level:** 
- [ ] Very confident in system safety
- [ ] Confident with minor concerns
- [ ] Moderate concerns about rollout
- [ ] Significant safety concerns

**Major strengths:**
_______________________________________________

**Areas for improvement:**
_______________________________________________

**Risks identified:**
_______________________________________________

---

## APPROVALS

**Clinical Lead Review:**

Name: ________________________  
Title: ________________________  
Signature: ________________________  Date: __________

Comments: _______________________________________________

---

**Compliance Officer Review:**

Name: ________________________  
Title: ________________________  
Signature: ________________________  Date: __________

Comments: _______________________________________________

---

**QA Lead Review:**

Name: ________________________  
Title: ________________________  
Signature: ________________________  Date: __________

Comments: _______________________________________________

---

## NEXT STEPS

**If APPROVED FOR CONTROLLED PILOT:**
1. Send this report to engineering team
2. Pilot execution begins (May 14-16)
3. Database verification runs in parallel
4. Results compiled into CONTROLLED_PILOT_RESULTS_REPORT.md

**If APPROVED WITH CHANGES:**
1. Engineering team implements required changes
2. Clinical team conducts follow-up review
3. If re-review passes: Proceed to pilot
4. If re-review fails: Document and escalate

**If NOT APPROVED:**
1. Document blocking issues
2. Schedule meeting with engineering team
3. Discuss mitigation strategies
4. Schedule re-review after changes

---

**Status:** Clinical Review Complete  
**Verdict:** [To be filled by clinical team]  
**Date:** [To be filled by clinical team]  
**Next Phase:** Pilot execution (if approved)

